Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 8351 - 8375 of 10646 in total
Experimental
Matched Name: … 4-O-methyl-alpha-D-glucuronic acid …
Matched Iupac: … (2S,3S,4R,5R,6S)-4,5,6-trihydroxy-3-methoxyoxane-2-carboxylic acid …
Experimental
Matched Name: … Pyridoxyl-Glutamic Acid-5'-Monophosphate …
Matched Iupac: … 4-({[(1S)-1,3-dicarboxypropyl]amino}methyl)-3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-1-ium …
Experimental
Matched Name: … Bis(5-Amidino-2-Benzimidazolyl)Methanone …
Matched Iupac: … 2-(6-carbamimidoyl-1H-1,3-benzodiazole-2-carbonyl)-1H-1,3-benzodiazole-5-carboximidamide …
Tinostamustine is under investigation in clinical trial NCT03452930 (Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma).
Investigational
Matched Iupac: … 7-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}-N-hydroxyheptanamide …
Experimental
Investigational
Matched Synonyms: … 4-methylumbelliferone …
Matched Iupac: … 7-hydroxy-4-methyl-2H-chromen-2-one …
Lerociclib is under investigation in clinical trial NCT02983071 (G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-positive, Her2-negative Locally Advanced or Metastatic Breast Cancer).
Investigational
Matched Iupac: … 12'-({5-[4-(propan-2-yl)piperazin-1-yl]pyridin-2-yl}amino)-2',5',11',13'-tetraazaspiro[cyclohexane-1,3 …
Matched Description: … Lerociclib is under investigation in clinical trial NCT02983071 (G1T38, a CDK 4/6 Inhibitor, in Combination …
Investigational
Experimental
Matched Name: … 2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL …
Matched Iupac: … (2R)-2-[(1R,2S)-2-hydroxycyclopentyl]pent-4-enal …
Experimental
Matched Name: … 2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE …
Matched Iupac: … (2S)-2-amino-3-{2,4-dihydroxy-5-[(E)-(2-phenylethylidene)amino]phenyl}propanoic acid …
Experimental
Matched Iupac: … (2S)-2-dodecanamido-3-(4-hydroxyphenyl)propanoic acid …
Enrofloxacin is an antibiotic agent from the fluoroquinolone family produced by the Bayer Corporation. Enrofloxacin is approved by the FDA for its veterinary use. Due to the identification of fluoroquinolone-resistant strains of Campylobacter, in September 2005, the FDA withdrew the approval of enrofloxacin for its use in water to treat...
Vet approved
Matched Iupac: … 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid …
Experimental
Matched Name: … 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide …
Matched Iupac: … N-[4-(aminomethyl)phenyl]-6-carbamimidoyl-4-[(pyrimidin-2-yl)amino]naphthalene-2-carboxamide …
Experimental
Matched Name: … 4-acetamido-2,4-didexoy-D-glycero-beta-D-galacto-octopyranosylphosphonic acid …
Matched Iupac: … [(2S,4S,5R,6R)-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]phosphonic acid …
Experimental
Matched Name: … (1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid …
Matched Iupac: … [(1S)-1-{4'-methoxy-[1,1'-biphenyl]-4-sulfonamido}-2-methylpropyl]phosphonic acid …
Tesmilifene is a novel potentiator of chemotherapy which, when added to doxorubicin, achieved an unexpected and very large survival advantage over doxorubicin alone in a randomized trial in advanced breast cancer.
Investigational
Matched Synonyms: … N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine …
Matched Iupac: … [2-(4-benzylphenoxy)ethyl]diethylamine …
Investigational
Experimental
Matched Name: … N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine …
Matched Iupac: … (2S)-2-amino-5-(N'-hydroxycarbamimidamido)pentanoic acid …
Vilamakitug is under investigation in clinical trial NCT05201352 (Evaluation of Efficacy of Trifluridine/tipiracil Plus an Anti-il-1α True Human Antibody Versus Trifluridine/tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine).
Investigational
Matched Synonyms: … (human monoclonal xb2001 .gamma.4-chain), disulfide with human monoclonal xb2001 .kappa. …
Experimental
Matched Iupac: … (2S)-3-(acetyloxy)-2-aminopropanoic acid …
Experimental
Matched Name: … 4-(2-aminoethyl)-2-cyclohexylphenol …
Matched Iupac: … 4-(2-aminoethyl)-2-cyclohexylphenol …
Experimental
Matched Name: … 4-TERT-BUTYLBENZENESULFONIC ACID …
Matched Iupac: … 4-tert-butylbenzene-1-sulfonic acid …
Experimental
Matched Synonyms: … 4-dimethylamino-N-(6-hydroxycarbamoylhexyl)benzamide ... N-hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide …
Matched Name: … 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide …
Matched Iupac: … 7-{[4-(dimethylamino)phenyl]formamido}-N-hydroxyheptanamide …
Experimental
Matched Synonyms: … 4-O-β-D-mannopyranosyl-β-D-mannopyranose …
Matched Iupac: … (2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5S,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy …
Oregovomab is a murine monoclonal antibody that attaches to the tumor-associated antigen CA125.
Investigational
Displaying drugs 8351 - 8375 of 10646 in total